Vincent Medical (HKG:1612) expects an attributable profit of at least HK$50 million for the six months ended June 30, up over 50% from HK$33.3 million a year prior, a Thursday Hong Kong bourse filing said.
The medical device maker attributed the anticipated higher profit mainly to an increase in revenue amid a boost in sales orders from the imaging disposable products segment, as well as an improved gross profit margin.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.